Targeting tumour energy metabolism potentiates the cytotoxicity of 5-Aminolevulinic acid photodynamic therapy

British Journal of Cancer

Volumn 109, Issue 4, 2013, Pages 976-982

  Golding, J P ^a   Wardhaugh, T ^a   Patrick, L ^a   Turner, M ^a   Phillips, J B ^a   Bruce, J I ^a   Kimani, S G ^a,b  

^a OPEN UNIVERSITY   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINOLEVULINIC ACID; ANTINEOPLASTIC AGENT; BROMOPYRUVIC ACID; DEOXYGLUCOSE; LONIDAMINE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CELL; BREAST EPITHELIUM; CELL COUNT; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL SURVIVAL; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; ENERGY METABOLISM; EPITHELIUM CELL; GLYCOLYSIS; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR CELL;

ADENOSINE TRIPHOSPHATE; AMINOLEVULINIC ACID; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; DEOXYGLUCOSE; DRUG ADMINISTRATION SCHEDULE; GLYCOLYSIS; HEXOKINASE; HUMANS; INDAZOLES; MAMMARY GLANDS, HUMAN; MCF-7 CELLS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES; TUMOR STEM CELL ASSAY;

EID: 84883156066     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2013.391     Document Type: Article

References (43)

1. Anand S, Ortel BJ, Pereira SP, Hasan T, Maytin EV (2012) Biomodulatory approaches to photodynamic therapy for solid tumors. Cancer Lett 326: 8-16.
2. Aykin-Burns N, Ahmad IM, Zhu Y, Oberley LW, Spitz DR (2009) Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation. Biochem J 418: 29-37.
3. Bown SG (2012) How mainstream medicine sees photodynamic therapy in the United Kingdom. J Natl Compr Canc Netw 10(Suppl 2): S69-S74.
4. Brawer MK (2005) Lonidamine: basic science and rationale for treatment of prostatic proliferative disorders. Rev Urol 7(Suppl 7): S21-S26.
5. Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11: 85-95.
6. Calvino E, Estan MC, Simon GP, Sancho P, Boyano-Adanez Mdel C, de Blas E, Breard J, Aller P (2011) Increased apoptotic efficacy of lonidamine plus arsenic trioxide combination in human leukemia cells. Reactive oxygen species generation and defensive protein kinase (MEK/ERK, Akt/mTOR) modulation. Biochem Pharmacol 82: 1619-1629.
7. Chen EI (2012) Mitochondrial dysfunction and cancer metastasis. J Bioenerg Biomembr 44: 619-622.
8. Coleman MC, Asbury CR, Daniels D, Du J, Aykin-Burns N, Smith BJ, Li L, Spitz DR, Cullen JJ (2008) 2-deoxy-D-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer. Free Radic Biol Med 44: 322-331.
9. Cuperlovic-Culf M, Culf A, Touaibia M, Lefort N (2012) Targeting the latest hallmark of cancer: another attempt at 'magic bullet' drugs targeting cancers' metabolic phenotype. Future Oncol 8: 1315-1330.
10. Dahle J, Angell-Petersen E, Steen HB, Moan J (2001) Bystander effects in cell death induced by photodynamic treatment UVA radiation and inhibitors of ATP synthesis. Photochem Photobiol 73: 378-387.
11. Diez B, Ernst G, TeijoMJ, Batlle A, Hajos S, Fukuda H (2012) Combined chemotherapy and ALA-based photodynamic therapy in leukemic murine cells. Leuk Res 36: 1179-1184.
12. Dwarakanath BS (2009) Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro. J Cancer Res Ther 5(Suppl 1): S27-S31.
13. Enns L, Ladiges W (2012) Mitochondrial redox signaling and cancer invasiveness. J Bioenerg Biomembr 44: 635-638.
14. Gatzemeier U, Toomes H, Picollo R, Christoffel V, Lucker PW, Ulmer J (1991) Single-And multiple dose pharmacokinetics of lonidamine in patients suffering from non-small-cell lung cancer. Arzneimittelforschung 41: 436-439.
15. Gederaas OA, Holroyd A, Brown SB, Vernon D, Moan J, Berg K (2001) 5-Aminolaevulinic acid methyl ester transport on amino acid carriers in a human colon adenocarcinoma cell line. Photochem Photobiol 73: 164-169.
16. Hernlund E, Ihrlund LS, Khan O, Ates YO, Linder S, Panaretakis T, Shoshan MC (2008) Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir. Int J Cancer 123: 476-483.
17. Ji HT, Chien LT, Lin YH, Chien HF, Chen CT (2010) 5-ALA mediated photodynamic therapy induces autophagic cell death via AMP-Activated protein kinase. Mol Cancer 9: 91.
18. Kern ER, Glasgow LA, Klein RJ, Friedman-Kien AE (1982) Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus. J Infect Dis 146: 159-166.
19. Kim JS, Ahn KJ, Kim JA, Kim HM, Lee JD, Lee JM, Kim SJ, Park JH (2008) Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells: ROS-mediated cell death by 3-BrPA. J Bioenerg Biomembr 40: 607-618.
20. Kirveliene V, Sadauskaite A, Kadziauskas J, Sasnauskiene S, Juodka B (2003) Correlation of death modes of photosensitized cells with intracellular ATP concentration. FEBS Lett 553: 167-172.
21. Kroemer G, Pouyssegur J (2008) Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13: 472-482.
22. Milla Sanabria L, Rodriguez ME, Cogno IS, Rumie Vittar NB, Pansa MF, Lamberti MJ, Rivarola VA (2012) Direct and indirect photodynamic therapy effects on the cellular and molecular components of the tumor microenvironment. Biochim Biophys Acta 1835: 36-45.
23. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A, Saavedra E (2007) Energy metabolism in tumor cells. Febs J 274: 1393-1418.
24. Morton CA, McKenna KE, Rhodes LE (2008) Guidelines for topical photodynamic therapy: update. Br J Dermatol 159: 1245-1266.
25. Mroz P, Szokalska A, Wu MX, Hamblin MR (2010) Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS One 5: e15194.
26. Nakano A, Tsuji D, Miki H, Cui Q, El Sayed SM, Ikegame A, Oda A, Amou H, Nakamura S, Harada T, Fujii S, Kagawa K, Takeuchi K, Sakai A, Ozaki S, Okano K, Nakamura T, Itoh K, Matsumoto T, Abe M (2011) Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cells. PLoS One 6: e27222.
27. Noodt BB, Rodal GH, Wainwright M, Peng Q, Horobin R, Nesland JM, Berg K (1998) Apoptosis induction by different pathways with methylene blue derivative and light from mitochondrial sites in V79 cells. Int J Cancer 75: 941-948.
28. Oberdanner CB, Kiesslich T, Krammer B, Plaetzer K (2002) Glucose is required to maintain high ATP-levels for the energy-utilizing steps during PDT-induced apoptosis. Photochem Photobiol 76: 695-703.
29. Oleinick NL, Evans HH (1998) The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 150: S146-S156.
30. Pelicano H, Martin DS, Xu RH, Huang P (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646.
31. Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, da-Silva WS, Almeida FC, Da Poian AT, Galina A (2009) Inhibition of energyproducing pathways of HepG2 cells by 3-bromopyruvate. Biochem J 417: 717-726.
32. Qie S, Liang D, Yin C, Gu W, Meng M, Wang C, Sang N (2012) Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming. Cell Cycle 11: 3679-3690.
33. Ravagnan L, Marzo I, Costantini P, Susin SA, Zamzami N, Petit PX, Hirsch F, Goulbern M, Poupon MF, Miccoli L, Xie Z, Reed JC, Kroemer G (1999) Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore. Oncogene 18: 2537-2546.
34. Reubold TF, Eschenburg S (2012) A molecular view on signal transduction by the apoptosome. Cell Signal 24: 1420-1425.
35. Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B (2008) Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs 17: 1533-1545.
36. Shevchuk I, Chekulayev V, Moan J, Berg K (1996) Effects of the inhibitors of energy metabolism, lonidamine and levamisole, on 5-Aminolevulinic- Acidinduced photochemotherapy. Int J Cancer 67: 791-799.
37. Shoshan MC (2012) 3-Bromopyruvate: targets and outcomes. J Bioenerg Biomembr 44: 7-15.
38. Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8: 579-591.
39. Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033.
40. Wartenberg M, Richter M, Datchev A, Gunther S, Milosevic N, Bekhite MM, Figulla HR, Aran JM, Petriz J, Sauer H (2010) Glycolytic pyruvate regulates P-Glycoprotein expression in multicellular tumor spheroids via modulation of the intracellular redox state. J Cell Biochem 109: 434-446.
41. Zagorodna O, Martin SM, Rutkowski DT, Kuwana T, Spitz DR, Knudson CM (2012) 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines. Oncogene 31: 2738-2749.
42. Zhang Y, Yang JM (2013) Altered energy metabolism in cancer: A unique opportunity for therapeutic intervention. Cancer Biol Ther 14: 81-89.
43. Zuluaga MF, Lange N (2008) Combination of photodynamic therapy with anti-cancer agents. Curr Med Chem 15: 1655-1673.